Cure Rare Disease Expands Leadership Team to Accelerate Treatments for Ultra-Rare Conditions

Cure Rare Disease (CRD), a pioneering nonprofit biotechnology organization, has announced the addition of new scientific and strategic leaders, marking a significant step forward in its mission to develop therapies…

Continue Reading Cure Rare Disease Expands Leadership Team to Accelerate Treatments for Ultra-Rare Conditions

New European Project Aims to Improve Rare Disease Diagnosis and Care: Insights from the RARE-Impact Initiative

A recent article published in the Orphanet Journal of Rare Diseases highlights the launch and goals of RARE-Impact, a new European project designed to enhance the diagnosis, care, and overall…

Continue Reading New European Project Aims to Improve Rare Disease Diagnosis and Care: Insights from the RARE-Impact Initiative

After a Nationwide Outbreak of EV-D68 in 2014, the CDC Suggests Caution When Treating Children for Respiratory Disease

In 2014 the U.S. experienced a nationwide outbreak of EV-D68, raising concerns about children’s respiratory health. Acute flaccid myelitis disease (AFM) also spiked. EV-D68 is defined as a group of…

Continue Reading After a Nationwide Outbreak of EV-D68 in 2014, the CDC Suggests Caution When Treating Children for Respiratory Disease

Dancing Through Diagnosis: Alnylam’s Givlaari Campaign Puts Rare Disease in the Spotlight

Alnylam Pharmaceuticals has launched a unique promotional campaign for Givlaari, its treatment for acute hepatic porphyria (AHP), that swaps the usual clinical narratives for something more artistic: dance. As reported…

Continue Reading Dancing Through Diagnosis: Alnylam’s Givlaari Campaign Puts Rare Disease in the Spotlight

World’s First Personalized Gene-Editing Therapy Offers Hope to Infant with Rare Disease

In a groundbreaking medical achievement, physicians have administered the world’s first personalized gene-editing therapy to an infant suffering from a rare and fatal genetic disorder. The innovative treatment, described at…

Continue Reading World’s First Personalized Gene-Editing Therapy Offers Hope to Infant with Rare Disease